Patent ID: 9284276
Filing Date: 2016-03-15
CPC Classification: A61J,A61K,A61P,B65D,C07D

Claim Text:
1. A pharmaceutical composition comprising laquinimod or a pharmaceutically acceptable salt thereof, and 1) N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide or a salt thereof, wherein N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide is present in the composition in an amount greater than about 0.02% and less than about 0.50%, by weight, relative to the amount of laquinimod, based on a determination by an HPLC method; or 2) at least one pharmaceutically acceptable carrier, and a light-resistant coating wherein the coating is resistant to light with wavelength in the range of 310-400 nm.